Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleBehavioral Pharmacology

The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits

J. M. Witkin, J. A. Monn, D. D. Schoepp, X. Li, C. Overshiner, S. N. Mitchell, G. Carter, B. Johnson, K. Rasmussen and L. M. Rorick-Kehn
Journal of Pharmacology and Experimental Therapeutics July 2016, 358 (1) 71-82; DOI: https://doi.org/10.1124/jpet.116.233627
J. M. Witkin
Departments of Neuroscience and Discovery Chemistry, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (J.M.W., J.A.M., D.D.S., X.L., C.O., B.J., K.R., L.M.R.-K.), and Windlesham, Surrey, UK (S.N.M., G.C.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. A. Monn
Departments of Neuroscience and Discovery Chemistry, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (J.M.W., J.A.M., D.D.S., X.L., C.O., B.J., K.R., L.M.R.-K.), and Windlesham, Surrey, UK (S.N.M., G.C.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. D. Schoepp
Departments of Neuroscience and Discovery Chemistry, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (J.M.W., J.A.M., D.D.S., X.L., C.O., B.J., K.R., L.M.R.-K.), and Windlesham, Surrey, UK (S.N.M., G.C.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
X. Li
Departments of Neuroscience and Discovery Chemistry, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (J.M.W., J.A.M., D.D.S., X.L., C.O., B.J., K.R., L.M.R.-K.), and Windlesham, Surrey, UK (S.N.M., G.C.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Overshiner
Departments of Neuroscience and Discovery Chemistry, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (J.M.W., J.A.M., D.D.S., X.L., C.O., B.J., K.R., L.M.R.-K.), and Windlesham, Surrey, UK (S.N.M., G.C.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. N. Mitchell
Departments of Neuroscience and Discovery Chemistry, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (J.M.W., J.A.M., D.D.S., X.L., C.O., B.J., K.R., L.M.R.-K.), and Windlesham, Surrey, UK (S.N.M., G.C.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Carter
Departments of Neuroscience and Discovery Chemistry, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (J.M.W., J.A.M., D.D.S., X.L., C.O., B.J., K.R., L.M.R.-K.), and Windlesham, Surrey, UK (S.N.M., G.C.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. Johnson
Departments of Neuroscience and Discovery Chemistry, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (J.M.W., J.A.M., D.D.S., X.L., C.O., B.J., K.R., L.M.R.-K.), and Windlesham, Surrey, UK (S.N.M., G.C.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. Rasmussen
Departments of Neuroscience and Discovery Chemistry, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (J.M.W., J.A.M., D.D.S., X.L., C.O., B.J., K.R., L.M.R.-K.), and Windlesham, Surrey, UK (S.N.M., G.C.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. M. Rorick-Kehn
Departments of Neuroscience and Discovery Chemistry, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (J.M.W., J.A.M., D.D.S., X.L., C.O., B.J., K.R., L.M.R.-K.), and Windlesham, Surrey, UK (S.N.M., G.C.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 358 no. 1 71-82
DOI 
https://doi.org/10.1124/jpet.116.233627
PubMed 
27189960

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received March 18, 2016
  • Accepted May 10, 2016
  • Published online June 8, 2016.

Article Versions

  • Earlier version (May 12, 2016 - 08:44).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. J. M. Witkin,
  2. J. A. Monn,
  3. D. D. Schoepp,
  4. X. Li,
  5. C. Overshiner,
  6. S. N. Mitchell,
  7. G. Carter,
  8. B. Johnson,
  9. K. Rasmussen, and
  10. L. M. Rorick-Kehn
  1. Departments of Neuroscience and Discovery Chemistry, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana (J.M.W., J.A.M., D.D.S., X.L., C.O., B.J., K.R., L.M.R.-K.), and Windlesham, Surrey, UK (S.N.M., G.C.)
  1. Address correspondence to:
    Dr. Jeffrey M. Witkin, Lilly Research Laboratories; Lilly Corporate Center, Indianapolis, IN 46285-0510. E-mail: jwitkin{at}lilly.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: May 2016 to May 2023

AbstractFullPdf
May 20163051189
Jun 201684048164
Jul 20161623539
Aug 20161301325
Sep 2016871420
Oct 20161272119
Nov 201667198
Dec 2016242115
Jan 2017571410
Feb 20171012622
Mar 2017242326
Apr 2017521412
May 2017291919
Jun 201753014
Jul 2017316242
Aug 2017519235
Sep 2017524946
Oct 201753329
Nov 201737344
Dec 201744717
Jan 201845022
Feb 201856532
Mar 201886732
Apr 2018540430
May 2018615647
Jun 201839127
Jul 2018112637
Aug 201856843
Sep 201853715
Oct 201855919
Nov 201836623
Dec 201836419
Jan 201995416
Feb 201957425
Mar 201956536
Apr 201975534
May 201923516
Jun 201933129
Jul 201943430
Aug 201953623
Sep 201935330
Oct 2019113922
Nov 201924027
Dec 201972315
Jan 202022410
Feb 202015023
Mar 202073121
Apr 202083231
May 202074031
Jun 202051313
Jul 202092016
Aug 202031916
Sep 20201010011
Oct 20205338
Nov 202042614
Dec 2020112613
Jan 202143510
Feb 2021122223
Mar 2021133510
Apr 2021152115
May 2021233619
Jun 202110268
Jul 202162716
Aug 202172015
Sep 202141718
Oct 202124117
Nov 202182430
Dec 2021133624
Jan 202242134
Feb 202253510
Mar 202283316
Apr 202282321
May 202282919
Jun 2022512111
Jul 20225864
Aug 20227895
Sep 202239111
Oct 202263123
Nov 20222310
Dec 20222755
Jan 20235394
Feb 202311583
Mar 20236386
Apr 20238075
May 20232044

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 358 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 358, Issue 1
1 Jul 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleBehavioral Pharmacology

Rapidly Acting Antidepressant Actions of LY341495

J. M. Witkin, J. A. Monn, D. D. Schoepp, X. Li, C. Overshiner, S. N. Mitchell, G. Carter, B. Johnson, K. Rasmussen and L. M. Rorick-Kehn
Journal of Pharmacology and Experimental Therapeutics July 1, 2016, 358 (1) 71-82; DOI: https://doi.org/10.1124/jpet.116.233627

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleBehavioral Pharmacology

Rapidly Acting Antidepressant Actions of LY341495

J. M. Witkin, J. A. Monn, D. D. Schoepp, X. Li, C. Overshiner, S. N. Mitchell, G. Carter, B. Johnson, K. Rasmussen and L. M. Rorick-Kehn
Journal of Pharmacology and Experimental Therapeutics July 1, 2016, 358 (1) 71-82; DOI: https://doi.org/10.1124/jpet.116.233627
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Conclusions
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Stimulus Effects of Nicotine Aerosol
  • PK and PD Effects of Metabolic Inhibition of Mitragynine
  • Cromakalim prodrugs are analgesics in chronic pain models
Show more Behavioral Pharmacology

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics